Literature DB >> 12617271

The use of quality of life measures in multiple sclerosis research.

M W Nortvedt1, T Riise.   

Abstract

Quality of life research contributes knowledge essential to the health and healthcare of multiple sclerosis (MS) patients. This article reviews 83 MS studies in English that have presented data on quality of life. The studies may be classified into three categories, according to the application and the main focus: 1) evaluating the development and validity of quality of life questionnaires and clinical scales (n = 27); 2) evaluating factors that might influence the quality of life or comparing the quality of life among various groups (n = 37); and 3) using quality of life questionnaires as outcome measures in medical trials and other interventions (n = 19). The studies have shown that quality of life questionnaires more broadly measure the impact of MS than do the most frequently used measures of disease activity and effects. Using quality of life measures provides additional information in evaluating the effects of treatment and in studying the development of the disease. Such information is crucial in planning interventions for MS patients. A challenge in this field is to improve the study designs, including reaching some agreement on how to measure the quality of life.

Entities:  

Mesh:

Year:  2003        PMID: 12617271     DOI: 10.1191/1352458503ms871oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  32 in total

1.  Impact of natalizumab on patient-reported outcomes in a clinical practice setting: a cross-sectional survey.

Authors:  Siddhesh A Kamat; Krithika Rajagopalan; Judith J Stephenson; Sonalee Agarwal
Journal:  Patient       Date:  2009-06-01       Impact factor: 3.883

2.  Quality of life and impairment in patients with multiple sclerosis.

Authors:  A-K Isaksson; G Ahlström; L-G Gunnarsson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-01       Impact factor: 10.154

3.  Long-term exercise improves functional impairment but not quality of life in multiple sclerosis.

Authors:  Anders Romberg; Arja Virtanen; Juhani Ruutiainen
Journal:  J Neurol       Date:  2005-03-16       Impact factor: 4.849

Review 4.  Menopause in multiple sclerosis: therapeutic considerations.

Authors:  Riley Bove; Tanuja Chitnis; Maria Houtchens
Journal:  J Neurol       Date:  2013-10-08       Impact factor: 4.849

5.  Change in the Health-Related Quality of Life of Multiple Sclerosis Patients over 5 Years.

Authors:  Wonita Janzen; Karen V L Turpin; Sharon A Warren; Ruth Ann Marrie; Kenneth G Warren
Journal:  Int J MS Care       Date:  2013

Review 6.  Quality of life in multiple sclerosis: determinants, measurement, and use in clinical practice.

Authors:  Deborah M Miller; Rebecca Allen
Journal:  Curr Neurol Neurosci Rep       Date:  2010-09       Impact factor: 5.081

7.  Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis.

Authors:  L Shinto; G Marracci; S Baldauf-Wagner; A Strehlow; V Yadav; L Stuber; D Bourdette
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2009-01-25       Impact factor: 4.006

8.  Self-perceived physical functioning and health status among fully ambulatory multiple sclerosis patients.

Authors:  Maura Pugliatti; Trond Riise; Monica W Nortvedt; Giovanni Carpentras; M Alessandra Sotgiu; Stefano Sotgiu; Giulio Rosati
Journal:  J Neurol       Date:  2008-02-20       Impact factor: 4.849

9.  Disability status and quality of life in multiple sclerosis: non-linearity of the Expanded Disability Status Scale (EDSS).

Authors:  Sabine Twork; Susanne Wiesmeth; Milena Spindler; Markus Wirtz; Sabine Schipper; Dieter Pöhlau; Jörg Klewer; Joachim Kugler
Journal:  Health Qual Life Outcomes       Date:  2010-06-07       Impact factor: 3.186

10.  Evidence-based educational guidelines for stroke survivors after discharge home.

Authors:  Sharon K Ostwald; Sally Davis; Gayle Hersch; Carolyn Kelley; Kyler M Godwin
Journal:  J Neurosci Nurs       Date:  2008-06       Impact factor: 1.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.